Vonda K. Douglas

Phase II Trial of Individualized Rituximab Dosing for Patients With CD20-Positive Lymphoproliferative Disorders

Lucio Gordan, William B. Grow, Annette Pusateri et al. · Journal of Clinical Oncology · 2005 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +15

Thrombopoietin Administered During Induction Chemotherapy to Patients With Acute Myeloid Leukemia Induces Transient Morphologic Changes That May Resemble Chronic Myeloproliferative Disorders

Vonda K. Douglas, Martin S. Tallman, Larry D. Cripe et al. · American Journal of Clinical Pathology · 2002 · 68 citations · Full text

Medicine, Hematology, Oncology +14

Lymphoid Aggregates in Bone Marrow Mimic Residual Lymphoma After Rituximab Therapy for Non-Hodgkin Lymphoma

Vonda K. Douglas, Leo I. Gordon, Charles L. Goolsby et al. · American Journal of Clinical Pathology · 1999 · 39 citations

Medicine, Hematology, Pathology +15

Hodgkin's lymphoma after post‐transplant lymphoproliferative disease in a renal transplant recipient

Vikas R. Dharnidharka, Vonda K. Douglas, Stephen P. Hunger et al. · Pediatric Transplantation · 2004 · 38 citations

Medicine, Hematology, Pathology +14

Control of group C meningococcal disease in Australian Aboriginal children by mass rifampicin chemoprophylaxis and vaccination

Michael C. Pearce, John Sheridan, B Masutti et al. · The Lancet · 1995 · 38 citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +10